NCT03455712

Brief Summary

Women with singleton pregnancies at one outpatient clinic to be recruited for controlled clinical trial. Over eight weeks, women 15 0/7--22 6/7 weeks' with at least one prior prenatal visit to be enrolled in the control group. Women 6 0/7--14 6/7 weeks' to be enrolled in the intervention group at their first prenatal visit and to receive a pregnancy-specific gestational weight gain card. Women to be encouraged to record their weight at each prenatal care visit. All women to complete a GWG knowledge--based questionnaire at 15 0/7-22 6/7 weeks'.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 6, 2018

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

4 months

First QC Date

February 27, 2018

Last Update Submit

April 23, 2024

Conditions

Keywords

PregnancyGestational weight gainWeight gainPatient educationPatient knowledgeInstitute of Medicine

Outcome Measures

Primary Outcomes (1)

  • Pregnancy-specific topic/guideline questionnaire responses

    Comparison of number of participants in control vs. intervention groups who correctly answer multiple choice and free response questions related to pregnancy-specific topics and guidelines following intervention.

    Outcome assessed up to 23 weeks gestation

Secondary Outcomes (1)

  • Pregnancy-specific topic/guideline questionnaire responses

    Outcome assessed up to 23 weeks gestation

Study Arms (2)

Intervention

EXPERIMENTAL

Subjects to receive the Gestational Weight Gain Card at enrollment in addition to standard prenatal care.

Behavioral: Gestational Weight Gain Card

Standard-of-Care

NO INTERVENTION

No intervention to be delivered. Subjects to receive standard prenatal care.

Interventions

The Gestational Weight Gain Card is designed to be an educational and weight gain tracking tool. Study subjects will be highly encouraged to use the GWG card to gain both important clinical information and to document weight measurements throughout their pregnancy.

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Singleton gestation
  • Primary prenatal care at MetroHealth Medical Center
  • Planning to deliver at MetroHealth Medical Center

You may not qualify if:

  • Prior diagnosis of eating disorder
  • Inadequate knowledge of English language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Weight GainGestational Weight Gain

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Erica Berggren, MD, MSCR

    Case Western Reserve University School of Medicine, MetroHealth Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Subjects to be enrolled into the intervention and standard-of-care groups depending on their gestational age at the time of consent during the expected 2 month period of enrollment. Any subject who is between 6 weeks 0 days and 14 weeks 6 days of pregnancy at the time of consent and who has had no prior prenatal visits will be enrolled in the intervention group. Any subject who is between 15 weeks 0 days to 22 weeks 6 days of pregnancy at the time of consent and who has had at least one prior prenatal visit will be enrolled in the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 27, 2018

First Posted

March 6, 2018

Study Start

June 27, 2016

Primary Completion

November 1, 2016

Study Completion

September 7, 2017

Last Updated

April 25, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share